RFCA
ISEE

R&F Capital Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

R&F Capital Advisors’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$202K Sell
55,091
-198,874
-78% -$840K 0.05% 557
2016
Q4 		$1.23M Buy
+253,965
New +$7.54M 0.43% 53

Other funds holding ISEE

SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

R&F Capital Advisors's ISEE Position: Q1 2017 in Review

R&F Capital Advisors reduced its IVERIC bio, Inc. Common Stock (ISEE) stake by 78% in Q1 2017, selling an estimated $840K and leaving 55,091 shares worth $202K. The position accounts for 0.05% of the portfolio, ranked #557.

R&F Capital Advisors first reported a position in ISEE in Q4 2016 and has held it in 2 quarters since. The position peaked at $1.23M in Q4 2016. 100 funds tracked by Wall St. Rank hold ISEE as of Q1 2017.

  • R&F Capital Advisors held 55,091 shares of IVERIC bio, Inc. Common Stock worth $202K as of Q1 2017.
  • R&F Capital Advisors sold 198,874 IVERIC bio, Inc. Common Stock shares in Q1 2017, an estimated $840K.
  • IVERIC bio, Inc. Common Stock made up 0.05% of R&F Capital Advisors's portfolio in Q1 2017, its #557 holding.
  • R&F Capital Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q4 2016 and has held it in 2 quarters since.
  • R&F Capital Advisors's IVERIC bio, Inc. Common Stock position peaked at $1.23M in Q4 2016.
  • 100 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.